A Study to Evaluate the Efficacy and Safety of ASP5094 in Patients With Rheumatoid Arthritis on Methotrexate
Status:
Completed
Trial end date:
2018-10-16
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy, safety and pharmacokinetics of
ASP5094 in patients with rheumatoid arthritis (RA) treated with background methotrexate
(MTX).